Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 2, 2004 - Issue 2
Submit an article Journal homepage
483
Views
25
CrossRef citations to date
0
Altmetric
Review

Emerging infectious diseases: vulnerabilities, contributing factors and approaches

Felissa R Lashley College of Nursing, Rutgers, The State University of New Jersey, 180 University Avenue, Ackerson Hall, Suite 102, Newark, NJ 07102, USA. [email protected]
Pages 299-316 | Published online: 10 Jan 2014

References

  • Lederberg J, Shope RE, Oaks SC Jr. Emerging infections: microbial threats to health in the United States. Institute of Medicine, National Academy Press, Washington, DC, USA (1992).
  • ••The first comprehensive report delineating threats of emerging infectious diseases.
  • Centers for Disease Control and Prevention. Addressing emerging infictious disease threats: a prevention strategy fir the United States. Department of Health and Human Services, Atlanta, GA, USA (1994).
  • Centers for Disease Control and Prevention. Preventing emewinginfictious disease threats: a prevention strategy fir the 21st century Department of Health and Human Services, Atlanta, GA, USA (1998).
  • Burroughs T, Knobler S, Lederberg J (Eds). The emergence of zoonotic diseases: understanding the impact on animal and human health. Institute of Medicine, National Academy Press, DC, USA (2002).
  • Najafi M, Burroughs T (Eds). The resistance phenomenon in microbes and infictious disease vectors: implications for human health and strategies for containment. Institute of Medicine, National Academy Press, DC, USA (2003).
  • Lashley FR. 'Categories and highlights of significant current emerging infectious diseases.' In: Emerging infectious diseases: trends and issues. Lashley FR, Durham JD (Eds). Springer Publishing Company, NY, USA, 43–71 (2002).
  • Lashley FR. 'Policy spotlight: emerging infectious disease.' In: Policy and politics in nursing and healthcam 4th edition. Mason DJ, Leavitt JK, Chaffee MK (Eds). Saunders, MO, USA, 722–727 (2002).
  • •Connects examples of social policy such as immigration with infectious disease threats.
  • Lederberg J (Eds). Microbial threats to health: Emergence, detection and response. Institute of Medicine, National Academy Press, DC, USA (2003).
  • ••Updates the 1992 report and delineates newstrategies for the future.
  • Chavers S, Fawal H, Vermund SH. An introduction to emerging and reemerging infectious diseases.' In: Emerging infectious diseases: trends and issues. Lashley FR, Durham JD (Eds). Springer Publishing Company, NY, USA, 3–22 (2002).
  • Haydon DT, Cleaveland S, Taylor LH, Laurenson MK. Identifying reservoirs of infection: a conceptual and practical challenge. Emerg. Infect. Dis. 8(12), 1468-1473.
  • Lashley FR, Durham JD (Eds). Emerging infectious diseases: trends and issues. Springer Publishing Company, NY, USA (2002).
  • •• Examines broad issues in emerging infectious diseases such as behavioral and cultural issues and the association of infection in some chronic diseases and cancer and also focuses on 17 specific diseases.
  • Lashley FR. Factors contributing to the occurrence of emerging infectious diseases. Biological Research for Nursing 4(4), 258–267 (2003).
  • Yang Z. Molecular epidemiology of tuberculosis. Front. Biosci. 8, D440—D450 (2003).
  • Tarasevich IV, Shaginyan IA, Mediannikov OY. Problems and perspectives of molecular epidemiology of infectious diseases. Ann. NY Acad. Sci. 990, 751–756 (2003).
  • Quirk M. The genomics revolution has arrived in infectious diseases. Lancet Infect. Dis. 3,66 (2003).
  • Kuo CC, Campbell LA. Chlamydial infection of the cardiovascular system. Front. Biosci. 8, E36—E43 (2003).
  • Lashley FR. 'The role of infection in some cancers and chronic diseases.' In: Emerging infectious diseases: trends and issues. Lashley FR, Durham JD (Eds). Springer Publishing Company, NY, USA 265–286 (2002).
  • Levin LI, Munger KL, Rubertone MV, et al. Multiple sclerosis and Epstein—Barr virus. JAMA 289, 1533–1536 (2003).
  • Hjalgrim H, Askling J, Rostgaard K, et al Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J. Med. 349, 1324–1332 (2003).
  • Morris JG Jr, Potter M. Emergence of new pathogens as a function of changes in host susceptibility. Emerg. Infect. Dis. 3(4), 433–441 (1997).
  • Singh N. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients. Lancet. Infect. Dis. 3,156–161 (2003).
  • Centers for Disease Control and Prevention. Diagnosis and management of foodborne illnesses: a primer for physicians. MMWR 50(RR-02), 1–69 (2001).
  • •A comprehensive look at the sources, diagnosis and treatment of foodbome diseases.
  • Winthrop KL, Palumbo MS, Farrar JA, et al Alfalfa sprouts and Salmonella kottbus infection: a multistate outbreak following inadequate seed disinfection with heat and chlorine. J. Food Prot. 66,13–17 (2003).
  • Gill CJ, Keene WE, Mohle-Boetani JC, et al Alfalfa seed decontamination in a Salmonella outbreak. Emerg. Infect. Dis. 9,474–479 (2003).
  • Taylor JL, Tuttle J, Pramukul T, et al An outbreak of cholera in Maryland associated with imported commercial frozen fresh coconut milk. J. Infect. Dis. 167,1330–1339 (1993).
  • Herwaldt BL. Cyclospora cayentanensis: a review focusing on the outbreaks of cyclosporiasis in the 1990s. Clin. Infict. Dis. 31,1040–1057 (2000).
  • •A comprehensive review of cyclosporiasis outbreaks.
  • Niu MT, Polish LB, Robertson BH, et al Multistate outbreak of hepatitis A associated with frozen strawberries. J Infict. Dis. 166, 518–524 (1992).
  • Centers for Disease Control and Prevention. Hepatitis A associated with consumption of frozen strawberries — Michigan, March 1997. MMWR 46,288,295 (1997).
  • Centers for Disease Control and Prevention. Hepatitis A outbreak associated with green onions at a restaurant — Monaca, Pennsylvania, 2003. MMWR 52, 1155–1157 (2003).
  • Tauxe RV. Emerging foodborne pathogens. Int. J. Food Microbial 78(1–2), 31–41 (2002).
  • Fahey BJ. 'Behavioral and cultural aspects of transmission and infection'. In: Emerging infectious diseases: trends and issues. Lashley FR, Durham JD (Eds). Springer Publishing Company, NY, USA, 349–369 (2002).
  • Chen LH, Barnett ED, Wilson ME. Preventing infectious diseases during and after international adoption. Ann. Int. Med. 139, 371–378 (2003).
  • Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J. Clin. Viral 27(1), 1–13 (2003).
  • World Health Organization. Travel advisory for Toronto (Canada) lifted. WER 78(18), 145 (2003).
  • Centers for Disease Control and Prevention. Bovine spongiform encephalopathy in a dairy cow — Washington State, 2003. MMWR 52,1280–1285.(2004).
  • Collins SJ, Lawson VA, Masters CL. Transmissible spongiform encephalopathies. Lancet 363, 51–61 (2004).
  • •Current knowledge on the transmissible spongiform encephalopathies.
  • Stephenson J. Researchers wrestle with spread and control of emerging infections. JAMA 287,2061–2063 (2002).
  • Hollinger FB, Kleinman S. Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectives. Transfusion 43,992–997 (2003).
  • Busch MB, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 289,959–962 (2003).
  • Centers for Disease Control and Prevention. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts —Japan, 1979–2003. MMWR 52(48), 1179–1181 (2003).
  • Pincock S. Patient's death from vCJD may be linked to blood transfusion. Lancet 363,43 (2004).
  • McNeil DG Jr. Rare infection threatens to spread in blood supply. New York Times, November 18 (2003).
  • Lindegren ML, Kobrynski L, Rasmussen SA, et al Applying public health strategies to primary immunodeficiency diseases. MMWR. 53 (RR01), 1–29 (2004).
  • •A good review of primary immunodeficiency diseases including current aspects of origin, prevention and treatment.
  • Wilson ME. The traveller and emerging infections: sentinel, courier, transmitter. J. Appl Microbial 94, Si-S11 (2003).
  • •An excellent view of the risks of emerging infectious diseases associated with various types of travel.
  • Lashley FR. 'Travel, recreation and emerging infectious diseases.' In: Emerging infectious diseases: trends and issues. Lashley FR, Durham JD (Eds). Springer Publishing Company, NY, USA, 287–301 (2002).
  • Cookson ST, Carballo M, Nolan CM, Keystone JS, Jong EC. Migrating populations — a closer view of who, why and so what. Emerg Infic. Dis. 7(3)(Suppl.) (2001).
  • Wilson ME. Travel and the emergence of infectious diseases. Emerg. Infic. Dis. 1, 39–45 (1995).
  • Bharti AR, Nally JE, RicaMi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet. Infect. Dis. 3,757–771 (2003).
  • Olsen SJ, Chang HL, Cheung TY, et al Transmission of the severe acute respiratory syndrome on aircraft. N Engl. J. Med 349, 2416–2422 (2003).
  • DeHart RL. Health issues of air travel. Ann. Rev. Public Health 24,133–151 (2003).
  • Isaacson M. Airport malaria: a review. Bull. WHO 67,737–743 (1989).
  • •An important look at the issue of airport malaria and transmission of emerging infectious diseases associated with travel.
  • Brotherton JM, Delpech VC, Gilbert GL, et al. A large outbreak of influenza A and B on a cruise ship causing widespread morbidity. Epidemiol Infic. 130,263–271 (2003).
  • Centers for Disease Control and Prevention. Outbreaks of gastroenteritis associated with noroviruses on cruise ships — United States, 2002. MMWR 51, 1112–1115 (2002).
  • Miller JM, Tam TW, Maloney S, et al. Cruise ships: high-risk passengers and the global spread of new influenza viruses. Clin. Infect. Dis. 31,433–438 (2000).
  • Centers for Disease Control and Prevention. Fatal respiratory diphtheria in a US traveler to Haiti — Pennsylvania, 2003. MMWR 52, 1285–1286 (2004).
  • Ho AY, Lopez AS, Eberhart MG, et al. Outbreak of cyclosporiasis associated with imported raspberries, Philadelphia, Pennsylvania, 2000. Emerg Infect. Dis. 8(8), 783–788 (2002).
  • Doller PC, Dietrich K, Filipp N, et al Cyclosporiasis outbreak in Germany associated with the consumption of salad. Emerg Infect. Dis. 8(9), 992–994 (2002).
  • Centers for Disease Control and Prevention. Reptile-associated salmonellosis — selected states, 1998-2002. MMWR 52, 1206–1209 (2003).
  • Weigel LM, Clewell DB, Gill SR, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302, 1569-1578.
  • Cohen FL, Tartasky D. Microbial resistance to drug therapy: a review. AJIC 25,51–64 (1997).
  • •A good review of the problem of microbial resistance and ways to prevent it.
  • Stokes GV. 'Microbial resistance to antibiotics.' In: Emerging infectious diseases: trends and issues. Lashley FR, Durham JD (Eds). Springer Publishing Company, NY, USA, 23–42 (2002).
  • Nutt AE. From savior to assassin. Sunday star-ledger, final edition, December 7,1–13 (2003).
  • Lashley FR. Clinical genetics in nursing practice 3rd edition. Springer Publishing Co, NY, USA (In press).
  • Kimman TG. Genetics of infectious disease susceptibility. Kluwer Academic Publishers, Boston, USA (2001).
  • •• A comprehensive look at the association of genetics and infectious disease susceptibility.
  • Epstein PR. Climate change and emerging infectious diseases. Microb. Infect. 3, 747–754 (2001).
  • Centers for Disease Control and Prevention. Coccidioidomycosis following the Northridge earthquake — California, 1994. MMWR 43(10), 194–195 (1994).
  • Centers for Disease Control and Prevention. Increase in coccidioidomycosis — Arizona, 1998–2001. MMWR 52(6), 109–112 (2003).
  • Beyrer C. Hidden epidemic of sexually transmitted diseases in China. JAMA 289, 1303–1305 (2003).
  • Beveridge D. Hong Kong to move SARS victims to camps. Associated Press April 1, (2003).
  • Breiman RF, Evans MR, Preiser W, et al. Role of China in the quest to define and control severe acute respiratory syndrome. Emerg. Infect. Dis. 9(9), 1037–1045 (2003).
  • Torök, TJ, Tauxe RV, Wise RP, et al. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 278,389–398 (1997).
  • Atshabar BB. Foreword. Crit. Rev. Micro. 29,79–80 (2003).
  • Tucker JB, Zilinskas RA. The 1971 smallpox outbreak in the Soviet city of Aralsk: implications for Variola virus as a bioterrorist threat. Introduction. Crit. Rev. Micro. 29,81–95 (2003).
  • Centers for Disease Control and Prevention. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR 49(RR-4), 1–18 (2000).
  • Varma JK, Greene KD, Reller ME, et al. An outbreak of Escherichia coli 0157 infection following exposure to a contaminated building. JAMA 290(20), 2709–2712 (2003).
  • Louis VR, Russek-Cohen E, Choopun N, et al. Predictability of Vibrio cholerae in Chesapeake Bay. Appl. Environ. Microbial 69,2773–2785 (2003).
  • Collins AE. Vulnerability to coastal cholera ecology. Soc. Sci. Med. 57, 1397–1407 (2003).
  • Patrick ME, Adcock PM, Gomez TM, et al. Salmonella Enteritidis infections, United States, 1985-1999. Emerg. Infect. Dis. 10(1), (2004).
  • Paddock CD, Childs JE. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin. Micro. Rev., 16(1), 37–64 (2003).
  • Snell NJ. Examining unmet needs in infectious disease. Drug Discovery Today, 8(1), 22–30 (2003).
  • Pottumarthy S, Limaye AP, Prentice JL, et al. Nocardia veterana, a new emerging pathogen. J. Clin. Microbial 41, 1705–1709 (2003).
  • Kandhai MC, Reij MW, Gorris LGM, et al. Occurrence of Enterobacter sakazakii in food production environments and households. Lancet 363,39–40.
  • Dodd RY, Leiby DA. Emerging infectious threats to the blood supply. Ann. Rev. Med. 55,191–207 (2004).
  • •A comprehensive review of infectious agents that have been or have the potential for transmission through transfusion.
  • Sampathkmar P. West Nile virus: epidemiology, clinical presentation, diagnosis and prevention. Mayo. Clin. Proc. 78,1137–1144 (2003).
  • Centers for Disease Control and Prevention. West Nile virus activity — United States, November 20–25,2003. MMWR 52(47), 1160 (2003).
  • Knudsen TB0, Kronborg G, Andersen. Death from the Nile crosses the Atlantic: the West Nile fever story. Scand. J. Infect. Dis. 35,820–825 (2003).
  • Umemura T, Tanaka E, Ostapowicz G, et al. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J. Infect. Dis. 188,1545–1552 (2003).
  • Schroter M, Laufs R, Zollner B, et al. A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance. J. Clin. Viral 27, 69–73 (2003).
  • Biagini P. Human circoviruses. Vet. Microbial 98,95–101 (2004).
  • Lam SK. Nipah virus — a potential agent of bioterrorism? Antiviral Research 57, 113–119 (2003).
  • McCormack JG, Allworth AM. Emerging viral infections in Australia. MJA 177, 45–49 (2002).
  • Chua KB. Nipah virus outbreak in Malaysia. J. Clin. Viral 26,265–275 (2003).
  • Shortridge KF, Gao P, Guan Y, et al. Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. Vet. Microbial 74, 141–147 (2000).
  • Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 362,1733–1745 (2003).
  • Webster RG. Wet markets — a continuing source of severe acute respiratory syndrome and influenza? Lancet 363, 234–236 (2004).
  • •An interesting description of live animal markets as related to infectious disease transmission from animals to humans.
  • Normile D. Stopping Asia's avian flu: a worrisome third outbreak. Science 303, 447 (2004).
  • No authors listed. Avian influenza: the threat looms. Lancet 363,257 (2004).
  • Van Den Hoogen BG, Van Doornum GJ, Fockens JC, et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J. Infect. Dis. 188,1571–1577 (2003).
  • Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J. Med. 350,443–450 (2004).
  • Peterson AT, Bauer JT, Mills JN. Ecologic and geographic distribution of filovirus disease. Emerg. Infect. Dis. 10(1), 40–47 (2004).
  • Khan, AS, Tshioko FK, Heymann DL, et al. The re-emergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect. Dis. 179\(Supp1.1), S76—S86 (1999).
  • Peters CJ, LeDuc JW. An introduction to Ebola: the virus and the disease. J. Infect. Dis. 179 (Supp1.1), IX—XVI (1999).
  • •A classic description of Ebola in the Democratic Republic of Congo.
  • Leroy EM, Rouquet P, Formenty P, et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303,387–390 (2004).
  • Vogel G. Ebola outbreaks may have had independent sources. Science 303,298–299 (2004).
  • Thacker PD. An Ebola epidemic simmers in Africa. JAMA 290,317–319 (2003).
  • Bausch DG, Borchert M, Grein T, et al Risk factors for Marburg hemorrhatic fever, Democratic Republic of the Congo. Emerg Infect. Dis. 9,1531–1537 (2003).
  • Dhar AD, Werchniak AE, Li Y, et al. Tanapox infection in a college student. N Engl J. Med 350,361–366 (2004).
  • Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbial Infect. 10\(Suppl. 1), 48–66 (2004).
  • MacKenzie WIZ, Hoxie NJ, Proctor ME, et al. A massive outbreak in Milwaukee of Qyptosporidium infection transmitted through the public water supply. N Engl J. Med. 331,161–167 (1994).
  • Chai JY, Choi MH, Yu JR, et al. Gymnophalloides seoi: a new human intestinal trematode. Trend. Parasitiol 19, 109–112 (2003).
  • Garcia HH, Gonzalez AE, Evans CAW, et al. Taenia solium cysticercosis. Lancet 361,547–556 (2003).
  • Schantz PM, Moore AC, Mufioz JL, et al. Neurocysticercosis in an orthodox Jewish community. N Engl J. Med 327, 692–695 (1992).
  • Sotelo J. Neurocysticercosis — is the elimination of parasites beneficial? N Engl J. Med 350,280–282 (2004).
  • Eckert J, Deplazes R Biological, epidemiological and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin. Micro. Rev. 17,107–135 (2004).
  • Centers for Disease Control and Prevention. Probable locally acquired mosquito-transmitted Plasmodium vivax infection — Suffolk County, New York, 1999. MMWR 49,495–498 (2000).
  • Ellis JT, Morrison DA, Reichel MR Genomics and its impact on parsitiology and the potential for development of new parasite control methods. DNA Cell Biol. 22(6), 395–403 (2003).
  • Le Bras J, Durand R. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam. Clin. Pharmacol. 17, 147–153 (2003).
  • Cable RG, Leiby DA. Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases. Curr. Opin. Hematol 10,405–411 (2003).
  • Alter M. How is Creutzfeldt-Jakob disease acquired? Neuroepidemiology 19, 55–61 (2000).
  • Irani DN, Johnson JT. Diagnosis and prevention of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Ann. Rev. Med. 54, 305–319 (2003).
  • Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK Lancet347, 921–925 (1996).
  • Brown P, Will RG, Bradley R, et al. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution and current concersns. Emerg Infect. Dis. 7, 6–16 (2001).
  • Hill AF, Collinge J. Subclinical prion infection in humans and animals. Br. Med. Bull. 66, 161–170 (2003).
  • Breiman RF, Evans MR, Preiser W, et al. Role of China in the quest to define and control severe acute respiratory syndrome. Emerg. Infect. Dis. 9(9), 1037–1045 (2003).
  • World Health Organization. Acute respiratory syndrome, China. Wkly Epidemiol. Rec. 78(7), 41–48 (2003).
  • Centers for Disease Control and Prevention. Update: severe acute respiratory syndrome — worldwide and United States, 2003. MMWR, 52(28), 664–665 (2003).
  • No authors listed. We have been warned. Nature 424(6945) (2003).
  • Ksiazek TG, Erdman D., Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl. J. Med. 348, 1953–1966 (2003).
  • •A rapid report on the cause of SARS.
  • Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus associatd with severe acute respiratory syndrome. N EngL J. Med. 348, 1967–1976 (2003).
  • •A rapid report on the cause of SARS.
  • Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325 (2003).
  • •A rapid report on the cause of SARS.
  • Wenzel RP, Edmond MB. Managing SARS amidst uncertainty. N Engl. J. Med. 348 1947–1948 (2003).
  • Gerberding JL. Faster...but fast enough? Responding to the epidemic of severe acute respiratory syndrome. N EngL J. Med. 348, 2030–2031 (2003).
  • Liu J. SARS wildlife and human health. Science 302, 53 (2003).
  • World Health Organization. Announcement of suspected severe acute respiratory syndrome (SARS) case, southern China — update. Weekly Epidemiological Record 79, 14–16 (2004).
  • Watts J. China culls wild animals to prevent new SARS threat. Lancet 363, 134 (2004).
  • Normile D. Viral DNA match spurs China's civet roundup. Science 303, 292 (2004).
  • Zheng BJ, Guan Y, Wong KH, et al. SARS-related virus predating SARS outbreak, Hong Kong. EID 10, 176–178 (2004).
  • Senior K. Recent Singapore SARS case a laboratory accident. Lancet. Infect. Dis. 3, 679 (2003).
  • Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet. Infect. Dis. 4, 15–25 (2004).
  • Centers for Disease Control and Prevention. Update: multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio and Wisconsin, 2003. MMWR 52(27), 642–646 (2003).
  • Stephenson J. Monkeypox outbreak a reminder of emerging infections vulnerabilities. /A/V/11290, 23–24 (2003).
  • Reed KD, Melski JW, Graham MB, et al The detection of monkeypox in humans in the Western hemisphere. N EngL J. Med 350, 342–350 (2004).
  • Austin CP. The impact of the completed human genome sequence on the development of novel therapeutics for human disease. Ann. Rev. Med 55, 1–13 (2004).
  • Lyte M. Microbial endocrinology and infectious disease in the 21st century. Trends MicrobioL 12, 14–20 (2004).
  • Bryant PA, Venter D, Robins-Browne R, et al Chips with everything: DNA microarrays in infectious diseases. Lancet. Infici. Dis. 4, 100–111 (2004).

Website

  • New York Times online. (Accessed March 2004). http://www.nytimes.com/2003/11/18/health /18INFE.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.